发明名称 |
Hepatitis C Virus Inhibitors |
摘要 |
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: Q-G-A-L-B-W  (I), which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
|
申请公布号 |
US2012076755(A1) |
申请公布日期 |
2012.03.29 |
申请号 |
US201113252818 |
申请日期 |
2011.10.04 |
申请人 |
QIU YAO-LING;WANG CE;PENG XIAOWEN;YING LU;CAO HUI;OR YAT SUN;ENANTA PHARMACEUTICALS, INC. |
发明人 |
QIU YAO-LING;WANG CE;PENG XIAOWEN;YING LU;CAO HUI;OR YAT SUN |
分类号 |
A61K31/4188;A61K31/4196;A61K31/424;A61K31/427;A61K31/4439;A61K31/454;A61K31/5377;A61K38/21;A61K39/12;A61P1/16;A61P29/00;A61P31/14;A61P31/18;A61P37/02;C07D487/16;C12N7/06 |
主分类号 |
A61K31/4188 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|